Login to Your Account

Other News To Note

Wednesday, April 10, 2013
• InDex Pharmaceuticals AB, of Stockholm, Sweden, completed enrollment for its Phase III COLLECT study of Kappaproct.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription